Publikationen, an denen er mitarbeitet CARLOS JUAN LUMBRERAS BERMEJO (38)

2023

  1. Bacteremia in Patients with Solid Organ Cancer: Insights into Epidemiology and Antibiotic Consumption

    Cancers, Vol. 15, Núm. 23

  2. Disparities between Latinx migrants and Spanish natives in COVID-19 outcome in Madrid

    Pathogens and Global Health, Vol. 117, Núm. 6, pp. 590-595

  3. Enhancing screening adherence for strongyloides infection in latinx inpatients with COVID-19: a local protocol implementation study

    Pathogens and Global Health

2022

  1. A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem

    Internal and Emergency Medicine, Vol. 17, Núm. 2, pp. 515-524

  2. Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

    International Journal of Infectious Diseases, Vol. 117, pp. 56-64

  3. Higher mortality of hospitalized haematologic patients with COVID-19 compared to non-haematologic is driven by thrombotic complications and development of ARDS: An age-matched cohorts study

    Clinical Infection in Practice, Vol. 13

2021

  1. Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study

    Journal of Medical Virology, Vol. 93, Núm. 2, pp. 831-842

2020

  1. Incidence and clinical profiles of COVID-19 pneumonia in pregnant women: A single-centre cohort study from Spain

    EClinicalMedicine, Vol. 23

2013

  1. A non-compulsory stewardship programme for the management of antifungals in a university-affiliated hospital

    Clinical Microbiology and Infection, Vol. 19, Núm. 1, pp. 56-61

  2. Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation

    Clinical Microbiology and Infection, Vol. 19, Núm. 12, pp. 1132-1139

  3. Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation

    Transplant Infectious Disease, Vol. 15, Núm. 4, pp. 405-415

2011

  1. Guidelines for the treatment of invasive fungal disease by Aspergillus spp. and other fungi issued by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2011 Update

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. 6, pp. 435-454

2009

  1. A new strategy of delayed long-term prophylaxis could prevent cytomegalovirus disease in (D+/R-) solid organ transplant recipients

    Clinical Transplantation, Vol. 23, Núm. 5, pp. 666-671

2007

  1. Clinical implications of respiratory virus infections in solid organ transplant recipients: A prospective study

    Transplantation, Vol. 84, Núm. 7, pp. 851-856

  2. Incidence, clinical characteristics and risk factors of late infection in solid organ transplant recipients: Data from the RESITRA Study Group

    American Journal of Transplantation, Vol. 7, Núm. 4, pp. 964-971

2006

  1. Brote nosocomial de gripe en pacientes hematológicos de alto riesgo. Eficacia de las medidas de control y del uso de zanamivir

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 24, Núm. 1, pp. 10-13

2005

  1. Accuracy of blood culture for early diagnosis of mediastinitis in febrile patients after cardiac surgery

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 24, Núm. 3, pp. 182-189

  2. PACTA: Efecto de un programa no impositivo de control y asesoramiento del tratamiento antibiótico sobre la disminución de los costes y el descenso de ciertas infecciones nosocomiales

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 23, Núm. 4, pp. 186-190

2004

  1. Aportación de los azoles de segunda generación en las infecciones por Candida spp.

    Revista Espanola de Quimioterapia

  2. Eficacia del tratamiento anticipado con ganciclovir en la prevención de la enfermedad por citomegalovirus en receptores de un trasplante de hígado

    Medicina Clinica, Vol. 122, Núm. 2, pp. 41-45